TY - JOUR
T1 - Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
AU - Stemler, Jannik
AU - Bruns, Caroline
AU - Mellinghoff, Sibylle C
AU - Alakel, Nael
AU - Akan, Hamdi
AU - Ananda-Rajah, Michelle
AU - Auberger, Jutta
AU - Bojko, Peter
AU - Chandrasekar, Pranatharthi H
AU - Chayakulkeeree, Methee
AU - Cozzi, José A
AU - de Kort, Elizabeth A
AU - Groll, Andreas H
AU - Heath, Christopher H
AU - Henze, Larissa
AU - Hernandez Jimenez, Marcos
AU - Kanj, Souha S
AU - Khanna, Nina
AU - Koldehoff, Michael
AU - Lee, Dong-Gun
AU - Mager, Alina
AU - Marchesi, Francesco
AU - Martino-Bufarull, Rodrigo
AU - Nucci, Marcio
AU - Oksi, Jarmo
AU - Pagano, Livio
AU - Phillips, Bob
AU - Prattes, Juergen
AU - Pyrpasopoulou, Athina
AU - Rabitsch, Werner
AU - Schalk, Enrico
AU - Schmidt-Hieber, Martin
AU - Sidharthan, Neeraj
AU - Soler-Palacín, Pere
AU - Stern, Anat
AU - Weinbergerová, Barbora
AU - El Zakhem, Aline
AU - Cornely, Oliver A
AU - Koehler, Philipp
N1 - © 2020, The Author(s).
PY - 2020/3/13
Y1 - 2020/3/13
N2 - Baseline chest computed tomography (BCT) in high-risk hematology patients allows for the early diagnosis of invasive pulmonary aspergillosis (IPA). The distribution of BCT implementation in hematology departments and impact on outcome is unknown. A web-based questionnaire was designed. International scientific bodies were invited. The estimated numbers of annually treated hematology patients, chest imaging timepoints and techniques, IPA rates, and follow-up imaging were assessed. In total, 142 physicians from 43 countries participated. The specialties included infectious diseases (n = 69; 49%), hematology (n = 68; 48%), and others (n = 41; 29%). BCT was performed in 57% (n = 54) of 92 hospitals. Upon the diagnosis of malignancy or admission, 48% and 24% performed BCT, respectively, and X-ray was performed in 48% and 69%, respectively. BCT was more often used in hematopoietic cell transplantation and in relapsed acute leukemia. European centers performed BCT in 59% and non-European centers in 53%. Median estimated IPA rate was 8% and did not differ between BCT (9%; IQR 5-15%) and non-BCT centers (7%; IQR 5-10%) (p = 0.69). Follow-up computed tomography (CT) for IPA was performed in 98% (n = 90) of centers. In high-risk hematology patients, baseline CT is becoming a standard-of-care. Chest X-ray, while inferior, is still widely used. Randomized, controlled trials are needed to investigate the impact of BCT on patient outcome.
AB - Baseline chest computed tomography (BCT) in high-risk hematology patients allows for the early diagnosis of invasive pulmonary aspergillosis (IPA). The distribution of BCT implementation in hematology departments and impact on outcome is unknown. A web-based questionnaire was designed. International scientific bodies were invited. The estimated numbers of annually treated hematology patients, chest imaging timepoints and techniques, IPA rates, and follow-up imaging were assessed. In total, 142 physicians from 43 countries participated. The specialties included infectious diseases (n = 69; 49%), hematology (n = 68; 48%), and others (n = 41; 29%). BCT was performed in 57% (n = 54) of 92 hospitals. Upon the diagnosis of malignancy or admission, 48% and 24% performed BCT, respectively, and X-ray was performed in 48% and 69%, respectively. BCT was more often used in hematopoietic cell transplantation and in relapsed acute leukemia. European centers performed BCT in 59% and non-European centers in 53%. Median estimated IPA rate was 8% and did not differ between BCT (9%; IQR 5-15%) and non-BCT centers (7%; IQR 5-10%) (p = 0.69). Follow-up computed tomography (CT) for IPA was performed in 98% (n = 90) of centers. In high-risk hematology patients, baseline CT is becoming a standard-of-care. Chest X-ray, while inferior, is still widely used. Randomized, controlled trials are needed to investigate the impact of BCT on patient outcome.
U2 - 10.3390/jof6010036
DO - 10.3390/jof6010036
M3 - Article
C2 - 32183235
SN - 2309-608X
VL - 6
SP - 1
EP - 12
JO - Journal of fungi (Basel, Switzerland)
JF - Journal of fungi (Basel, Switzerland)
IS - 1
ER -